Skaevinge, Denmark

Lene Sonderbye Kjaerulff

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

I specialize in the sphere of innovations, inventions, inventors, patent attorneys, assignees, and patents.

Title: The Innovations of Inventor Lene Sonderbye Kjaerulff

Introduction: Lene Sonderbye Kjaerulff, a talented inventor from Skaevinge, DK, has made a significant impact in the field of cancer treatment with his groundbreaking patent on LNA oligonucleotides.

Latest Patents: Lene Sonderbye Kjaerulff holds a remarkable patent on LNA oligonucleotides for the treatment of cancer. This innovation showcases the effectiveness of the LNA oligonucleotides in inhibiting the expression of Survivin, ultimately leading to the reduction or inhibition of tumor development in vivo.

Career Highlights: Throughout his career, Lene Sonderbye Kjaerulff has worked with reputable companies such as Santaris Pharma A/S and Enzon Pharmaceuticals, Inc. His expertise and contributions have undoubtedly played a crucial role in advancing the field of cancer research and treatment.

Collaborations: Lene Sonderbye Kjaerulff has collaborated with esteemed professionals in the industry, including Christoph Rosenbohm and Majken Westergaard. These collaborations have further enriched his innovative work in the field of cancer treatment.

Conclusion: In conclusion, Lene Sonderbye Kjaerulff's dedication to innovation and his pioneering work in the development of LNA oligonucleotides for cancer treatment underscore his importance in the field. His patent stands as a testament to his commitment to improving the lives of those affected by cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…